The "compensation committee," which consists of directors Kelly and Naydenov, not only voted to award 6,000,000 "performance shares" to Pourhassan, but 2,500,000 and 1,500,000, performance shares, respectively, to themselves.
That, to me, seems like a conflict of interest.
I wish we had an independent board of directors that was looking out for the interests of the shareholders, rather than for themselves.
LM
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
The Lawmanstyle="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]